Literature DB >> 8846648

B lymphocytes and humoral immune responses in rheumatoid arthritis.

L S De Clerck1.   

Abstract

Although the etiology of rheumatoid arthritis (RA) remains unknown at present, major evidence implicates humoral immune mechanisms in the pathophysiology of this disease. The primary lesions occur in the synovium and are characterized by immunological activation and chronic inflammation. Activated B cells and plasma cells secrete antibodies including rheumatoid factors and anticollagen antibodies. These antibodies give rise to immune complex formation and activation of the inflammatory cascade. There is no evidence that rheumatoid factor secreting B cells act as antigen presenting cells and present immune complex to T cells, leading to perpetuation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846648     DOI: 10.1007/bf02215852

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  54 in total

Review 1.  The immunopathology of joint inflammation in rheumatoid arthritis.

Authors:  N J Zvaifler
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

2.  Synovitis of recent onset. A clinicopathologic study during the first month of disease.

Authors:  H R Schumacher; R C Kitridou
Journal:  Arthritis Rheum       Date:  1972 Sep-Oct

3.  Clinical significance of immune complexes in rheumatoid disease.

Authors:  A Fleming; J Charlesworth; M Liew; I Portek; J Bertouch; J Quin
Journal:  Aust N Z J Med       Date:  1981-06

4.  Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases.

Authors:  D G Scott; P A Bacon; C R Tribe
Journal:  Medicine (Baltimore)       Date:  1981-07       Impact factor: 1.889

Review 5.  Rheumatoid factors in immune complexes of patients with rheumatoid arthritis.

Authors:  M Mannik; F A Nardella; E H Sasso
Journal:  Springer Semin Immunopathol       Date:  1988

6.  CD5 positive B cells in patients with rheumatoid arthritis: phorbol ester mediated enhancement of detection.

Authors:  P Youinou; L Mackenzie; J Jouquan; P Le Goff; P M Lydyard
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

7.  Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group.

Authors:  V Strand; P E Lipsky; G W Cannon; L H Calabrese; C Wiesenhutter; S B Cohen; N J Olsen; M L Lee; T J Lorenz; B Nelson
Journal:  Arthritis Rheum       Date:  1993-05

8.  IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease.

Authors:  M L Westedt; M R Daha; E de Vries; R M Valentijn; A Cats
Journal:  J Rheumatol       Date:  1985-06       Impact factor: 4.666

9.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

10.  Electron microscopic morphology of immunoglobulin aggregates and their interactions in rheumatoid articular collagenous tissues.

Authors:  O Ohno; T D Cooke
Journal:  Arthritis Rheum       Date:  1978-06
View more
  3 in total

1.  The levels of CD16/Fc gamma receptor IIIA on CD14+ CD16+ monocytes are higher in children with severe Plasmodium falciparum anemia than in children with cerebral or uncomplicated malaria.

Authors:  Lilian A Ogonda; Alloys S S Orago; Michael F Otieno; Christine Adhiambo; Walter Otieno; José A Stoute
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

2.  A study on FoxP3 and Tregs in paired samples of peripheral blood and synovium in rheumatoid arthritis.

Authors:  Usha Shalini P; Tanya Debnath; Vidyasagar Jvs; Lakshmi K Kona; Suguna R Kamaraju; Ravindranath Kancherla; Lakshmi K Chelluri
Journal:  Cent Eur J Immunol       Date:  2016-01-15       Impact factor: 2.085

3.  The anti-arthritis effect of sulforaphane, an activator of Nrf2, is associated with inhibition of both B cell differentiation and the production of inflammatory cytokines.

Authors:  Su-Jin Moon; Jooyeon Jhun; Jaeyoon Ryu; Ji Ye Kwon; Se-Young Kim; KyoungAh Jung; Mi-La Cho; Jun-Ki Min
Journal:  PLoS One       Date:  2021-02-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.